Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry
- PMID: 36754595
- DOI: 10.1136/oemed-2022-108669
Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry
Abstract
Objectives: Malignant mesothelioma is an uncommon cancer associated with asbestos exposure, predominantly occupational. Asbestos has been banned in Australia since 2003 but mesothelioma has a long latency and incident cases continue to present. The Australian Mesothelioma Registry was incepted to collect systematic data about incidence and mortality alongside asbestos exposure.
Methods: Benefiting from the Australian national system of cancer notification, all incident cases of mesothelioma in all states and territories are fast-tracked and notified regularly. Notified patients are contacted asking for consent to collect exposure information, initially by postal questionnaire and subsequently by telephone interview. Age-standardised annual incidence rates and mortality rates were calculated. Asbestos exposure was categorised as occupational, non-occupational, neither or, both; and as low, or high, probability of exposure.
Results: Mesothelioma incidence appears to have peaked. The age-standardised incidence rates have declined steadily since the early 2000s (peaking in males at 5.9/100 000 and in all-persons at 3.2/100 000), driven by rates in males, who comprise the majority of diagnosed cases. Rates in women have remained fairly stable since that time. Age-standardised mortality rates have followed similar trends. Mesothelioma remains the most common in those aged over 80 years. Nearly all (94%) cases were linked with asbestos exposure (78% occupational in men; 6.8% in women).
Conclusions: With effective control of occupational asbestos use, the decline in age-standardised incidence and death rates has occurred. Incidence rates among women, in whom occupational asbestos exposure is rarely detectable, remain unchanged, pointing to the role of household and /or environmental asbestos exposure.
Keywords: asbestos; mesothelioma; mortality; occupational health.
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
The Western Australian Mesothelioma Registry: Analysis of 60 years of cases.Respirology. 2024 Apr;29(4):288-294. doi: 10.1111/resp.14648. Epub 2023 Dec 28. Respirology. 2024. PMID: 38153786 Review.
-
Incidence of mesothelioma in young people and causal exposure to asbestos in the Italian national mesothelioma registry (ReNaM).Occup Environ Med. 2023 Nov;80(11):603-609. doi: 10.1136/oemed-2023-108983. Epub 2023 Oct 9. Occup Environ Med. 2023. PMID: 37813485
-
[Tuscany mesothelioma registry (1988-2000): evaluation of asbestos exposure].Med Lav. 2002 Nov-Dec;93(6):507-18. Med Lav. 2002. PMID: 12596421 Italian.
-
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections.Occup Environ Med. 2016 Sep;73(9):607-13. doi: 10.1136/oemed-2016-103652. Epub 2016 Jun 16. Occup Environ Med. 2016. PMID: 27312399 Free PMC article.
-
Malignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trends.J Toxicol Environ Health B Crit Rev. 2016;19(5-6):173-189. doi: 10.1080/10937404.2016.1194254. J Toxicol Environ Health B Crit Rev. 2016. PMID: 27705544 Review.
Cited by
-
A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.J Transl Med. 2023 Dec 2;21(1):875. doi: 10.1186/s12967-023-04761-9. J Transl Med. 2023. PMID: 38041166 Free PMC article.
-
Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil.J Bras Pneumol. 2024 May 13;50(2):e20230343. doi: 10.36416/1806-3756/e20230343. eCollection 2024. J Bras Pneumol. 2024. PMID: 38747814 Free PMC article.
-
Establishment and bioinformatics analysis of a four-miRNA prognostic signature for pleural mesothelioma.J Cancer. 2024 Oct 21;15(20):6505-6520. doi: 10.7150/jca.101914. eCollection 2024. J Cancer. 2024. PMID: 39668817 Free PMC article.
-
The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review.J Thorac Dis. 2024 Jan 30;16(1):671-687. doi: 10.21037/jtd-23-611. Epub 2024 Jan 10. J Thorac Dis. 2024. PMID: 38410609 Free PMC article. Review.
-
From Diagnosis to Survivorship: The Role of Social Determinants in Cancer Care.Cancers (Basel). 2025 Mar 22;17(7):1067. doi: 10.3390/cancers17071067. Cancers (Basel). 2025. PMID: 40227566 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical